Skip to main content
. 2024 Jun 1;109(6):1689–1699. doi: 10.3324/haematol.2023.284604

Table 2.

Studies describing the clinical experience with the use of universal, gene-edited CD19-chimeric antigen receptor T cells.

graphic file with name 1091689.tab2.jpg